CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
Detroit, Michigan, United States and 25 other locations
cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...
Phase 3
Detroit, Michigan, United States and 23 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Detroit, Michigan, United States and 213 other locations
(PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian ....
Phase 1, Phase 2
Detroit, Michigan, United States and 20 other locations
This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...
Phase 1
Detroit, Michigan, United States of America and 9 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Detroit, Michigan, United States and 70 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Detroit, Michigan, United States and 176 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Detroit, Michigan, United States and 50 other locations
in combination with belinostat in subjects with Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Meta ...
Phase 1
Ann Arbor, Michigan, United States
in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...
Phase 3
Ypsilanti, Michigan, United States and 117 other locations
Clinical trials
Research sites
Resources
Legal